CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Reviva Pharmaceuticals Holdings, Inc.

RVPH
$6MMicro Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for RVPH. That does not mean none is planned.

Get an email about RVPH's next catalysts

Track Reviva Pharmaceuticals Holdings (RVPH) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 1 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaCUPERTINO14 employees
Drug Pipeline

Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)

Frequently asked questions

What is in Reviva Pharmaceuticals Holdings, Inc.'s drug pipeline?β†’

CatalystAlert tracks 2 drug candidates in Reviva Pharmaceuticals Holdings, Inc.'s (RVPH) pipeline across Phase 3, Phase 2. Its lead program is Brilaroxazine (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Reviva Pharmaceuticals Holdings, Inc.'s next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for Reviva Pharmaceuticals Holdings, Inc. (RVPH) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track RVPH biotech catalysts?β†’

Add RVPH to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Reviva Pharmaceuticals Holdings, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply